This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Riddle MC (2005) Glycemic management of type 2 diabetes: an emerging strategy with oral agents, insulins, and combinations. Endocrinol Metab Clin North Am 34: 77–98
Riddle M (2000) Combining sulfonylureas and other oral agents. Am J Med 108 (Suppl 6A): 15S–22S
Zammitt NN et al. (2005) Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 28: 2948–2961
UK Prospective Diabetes Study (UKPDS) Group (1995) UK Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 44: 1249–1258
Hanefeld M et al. (2004) One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes. Diabetes Care 27: 141−147
Acknowledgements
The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author has received honoraria for consulting or lectures, or research support from Amylin, Bristol-Myers Squibb, GlaxoSmithkline NovoNordisk, Lilly, Pfizer, and SanofiAventis, manufacturers of various pharmaceutical agents for diabetes.
Rights and permissions
About this article
Cite this article
Riddle, M. Is initial combination therapy effective in the treatment of type 2 diabetes?. Nat Rev Endocrinol 2, 254–255 (2006). https://doi.org/10.1038/ncpendmet0167
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0167